Table of Content

1. Executive Summary
1.1. Global Gastrointestinal Infection Testing Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025 – 2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global GDP Growth Outlook
2.3.2. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors – Relevance and Impact
3. Value Added Insights
3.1. Regulatory Landscape
3.2. Product Adoption Analysis
3.3. Disease Epidemiology
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter’s Five Force Analysis
4. Global Gastrointestinal Infection Testing Market Outlook
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025–2032
4.3. Global Gastrointestinal Infection Testing Market Outlook: Product Type
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019 – 2023
4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
4.3.3.1. Instruments
4.3.3.2. Reagents & Consumables
4.3.4. Market Attractiveness Analysis: Product Type
4.4. Global Gastrointestinal Infection Testing Market Outlook: Test Type
4.4.1. Introduction / Key Findings
4.4.2. Historical Market Size (US$ Bn) Analysis, By Test Type, 2019 – 2023
4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025 – 2032
4.4.3.1. Molecular Tests
4.4.3.2. Immunoassays
4.4.3.3. Culture Tests
4.4.3.4. Others
4.4.4. Market Attractiveness Analysis: Test Type
4.5. Global Gastrointestinal Infection Testing Market Outlook: Infection Type
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Bn) Analysis, By Infection Type, 2019 – 2023
4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Infection Type, 2025 – 2032
4.5.3.1. Bacterial Infections
4.5.3.2. Viral Infections
4.5.3.3. Parasitic Infections
4.5.4. Market Attractiveness Analysis: Infection Type
4.6. Global Gastrointestinal Infection Testing Market Outlook: Sample Type
4.6.1. Introduction / Key Findings
4.6.2. Historical Market Size (US$ Bn) Analysis, By Sample Type, 2019 – 2023
4.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Sample Type, 2025 – 2032
4.6.3.1. Stool
4.6.3.2. Blood
4.6.3.3. Urine
4.6.3.4. Others
4.6.4. Market Attractiveness Analysis: Sample Type
4.7. Global Gastrointestinal Infection Testing Market Outlook: End User
4.7.1. Introduction / Key Findings
4.7.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 – 2023
4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2032
4.7.3.1. Hospitals
4.7.3.2. Diagnostic Laboratories
4.7.3.3. Ambulatory Surgery Centers (ASCs)
4.7.3.4. Research & Academic Institutes
4.7.3.5. Others
4.7.4. Market Attractiveness Analysis: End User
5. Global Gastrointestinal Infection Testing Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 – 2023
5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025 – 2032
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Gastrointestinal Infection Testing Market Outlook
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
6.2.1. By Country
6.2.2. By Product Type
6.2.3. By Test Type
6.2.4. By Infection Type
6.2.5. By Sample Type
6.2.6. By End User
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
6.4.1. Instruments
6.4.2. Reagents & Consumables
6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025 – 2032
6.5.1. Molecular Tests
6.5.2. Immunoassays
6.5.3. Culture Tests
6.5.4. Others
6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Infection Type, 2025 – 2032
6.6.1. Bacterial Infections
6.6.2. Viral Infections
6.6.3. Parasitic Infections
6.7. Current Market Size (US$ Bn) Analysis and Forecast, By Sample Type, 2025 – 2032
6.7.1. Stool
6.7.2. Blood
6.7.3. Urine
6.7.4. Others
6.8. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2032
6.8.1. Hospitals
6.8.2. Diagnostic Laboratories
6.8.3. Ambulatory Surgery Centers (ASCs)
6.8.4. Research & Academic Institutes
6.8.5. Others
6.9. Market Attractiveness Analysis
7. Europe Gastrointestinal Infection Testing Market Outlook
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
7.2.1. By Country
7.2.2. By Product Type
7.2.3. By Test Type
7.2.4. By Infection Type
7.2.5. By Sample Type
7.2.6. By End User
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Türkiye
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
7.4.1. Instruments
7.4.2. Reagents & Consumables
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025 – 2032
7.5.1. Molecular Tests
7.5.2. Immunoassays
7.5.3. Culture Tests
7.5.4. Others
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Infection Type, 2025 – 2032
7.6.1. Bacterial Infections
7.6.2. Viral Infections
7.6.3. Parasitic Infections
7.7. Current Market Size (US$ Bn) Analysis and Forecast, By Sample Type, 2025 – 2032
7.7.1. Stool
7.7.2. Blood
7.7.3. Urine
7.7.4. Others
7.8. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2032
7.8.1. Hospitals
7.8.2. Diagnostic Laboratories
7.8.3. Ambulatory Surgery Centers (ASCs)
7.8.4. Research & Academic Institutes
7.8.5. Others
7.9. Market Attractiveness Analysis
8. East Asia Gastrointestinal Infection Testing Market Outlook
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
8.2.1. By Country
8.2.2. By Product Type
8.2.3. By Test Type
8.2.4. By Infection Type
8.2.5. By Sample Type
8.2.6. By End User
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
8.4.1. Instruments
8.4.2. Reagents & Consumables
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025 – 2032
8.5.1. Molecular Tests
8.5.2. Immunoassays
8.5.3. Culture Tests
8.5.4. Others
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Infection Type, 2025 – 2032
8.6.1. Bacterial Infections
8.6.2. Viral Infections
8.6.3. Parasitic Infections
8.7. Current Market Size (US$ Bn) Analysis and Forecast, By Sample Type, 2025 – 2032
8.7.1. Stool
8.7.2. Blood
8.7.3. Urine
8.7.4. Others
8.8. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2032
8.8.1. Hospitals
8.8.2. Diagnostic Laboratories
8.8.3. Ambulatory Surgery Centers (ASCs)
8.8.4. Research & Academic Institutes
8.8.5. Others
8.9. Market Attractiveness Analysis
9. South Asia & Oceania Gastrointestinal Infection Testing Market Outlook
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
9.2.1. By Country
9.2.2. By Product Type
9.2.3. By Test Type
9.2.4. By Infection Type
9.2.5. By Sample Type
9.2.6. By End User
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
9.4.1. Instruments
9.4.2. Reagents & Consumables
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025 – 2032
9.5.1. Molecular Tests
9.5.2. Immunoassays
9.5.3. Culture Tests
9.5.4. Others
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Infection Type, 2025 – 2032
9.6.1. Bacterial Infections
9.6.2. Viral Infections
9.6.3. Parasitic Infections
9.7. Current Market Size (US$ Bn) Analysis and Forecast, By Sample Type, 2025 – 2032
9.7.1. Stool
9.7.2. Blood
9.7.3. Urine
9.7.4. Others
9.8. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2032
9.8.1. Hospitals
9.8.2. Diagnostic Laboratories
9.8.3. Ambulatory Surgery Centers (ASCs)
9.8.4. Research & Academic Institutes
9.8.5. Others
9.9. Market Attractiveness Analysis
10. Latin America Gastrointestinal Infection Testing Market Outlook
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
10.2.1. By Country
10.2.2. By Product Type
10.2.3. By Test Type
10.2.4. By Infection Type
10.2.5. By Sample Type
10.2.6. By End User
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
10.4.1. Instruments
10.4.2. Reagents & Consumables
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025 – 2032
10.5.1. Molecular Tests
10.5.2. Immunoassays
10.5.3. Culture Tests
10.5.4. Others
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Infection Type, 2025 – 2032
10.6.1. Bacterial Infections
10.6.2. Viral Infections
10.6.3. Parasitic Infections
10.7. Current Market Size (US$ Bn) Analysis and Forecast, By Sample Type, 2025 – 2032
10.7.1. Stool
10.7.2. Blood
10.7.3. Urine
10.7.4. Others
10.8. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2032
10.8.1. Hospitals
10.8.2. Diagnostic Laboratories
10.8.3. Ambulatory Surgery Centers (ASCs)
10.8.4. Research & Academic Institutes
10.8.5. Others
10.9. Market Attractiveness Analysis
11. Middle East & Africa Gastrointestinal Infection Testing Market Outlook
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
11.2.1. By Country
11.2.2. By Product Type
11.2.3. By Test Type
11.2.4. By Infection Type
11.2.5. By Sample Type
11.2.6. By End User
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
11.4.1. Instruments
11.4.2. Reagents & Consumables
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Test Type, 2025 – 2032
11.5.1. Molecular Tests
11.5.2. Immunoassays
11.5.3. Culture Tests
11.5.4. Others
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Infection Type, 2025 – 2032
11.6.1. Bacterial Infections
11.6.2. Viral Infections
11.6.3. Parasitic Infections
11.7. Current Market Size (US$ Bn) Analysis and Forecast, By Sample Type, 2025 – 2032
11.7.1. Stool
11.7.2. Blood
11.7.3. Urine
11.7.4. Others
11.8. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025 – 2032
11.8.1. Hospitals
11.8.2. Diagnostic Laboratories
11.8.3. Ambulatory Surgery Centers (ASCs)
11.8.4. Research & Academic Institutes
11.8.5. Others
11.9. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2025
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
12.3.1. Bio-Rad Laboratories, Inc.
12.3.1.1. Overview
12.3.1.2. Segments and Product Types
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Thermo Fisher Scientific, Inc.
12.3.3. Abbott Laboratories
12.3.4. F. Hoffmann-La Roche AG
12.3.5. Cepheid (a Danaher company)
12.3.6. DiaSorin S.p.A.
12.3.7. bioMérieux SA
12.3.8. Quidel Corporation
12.3.9. Hologic, Inc.
12.3.10. Becton, Dickinson and Company (BD)
12.3.11. Meridian Bioscience, Inc.
12.3.12. Qiagen N.V.
12.3.13. PerkinElmer, Inc.
12.3.14. Illumina, Inc.
12.3.15. Accelerate Diagnostics, Inc.
12.3.16. Seegene, Inc.
12.3.17. MP Biomedicals
12.3.18. Geneoscopy, Inc.
12.3.19. Others
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations